[HTML][HTML] Current evidence on the role of the gut microbiome in ADHD pathophysiology and therapeutic implications

A Checa-Ros, A Jeréz-Calero, A Molina-Carballo… - Nutrients, 2021 - mdpi.com
Studies suggest that the bidirectional relationship existent between the gut microbiome (GM)
and the central nervous system (CNS), or so-called the microbiome–gut–brain axis (MGBA) …

[HTML][HTML] ADHD: Reviewing the causes and evaluating solutions

L Núñez-Jaramillo, A Herrera-Solís… - Journal of personalized …, 2021 - mdpi.com
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder in which
patients present inattention, hyperactivity, and impulsivity. The etiology of this condition is …

[HTML][HTML] The potential influence of the bacterial microbiome on the development and progression of ADHD

S Bull-Larsen, MH Mohajeri - Nutrients, 2019 - mdpi.com
The latest research cumulates staggering information about the correlation between the
microbiota-gut-brain axis and neurodevelopmental disorders. This review aims to shed light …

[HTML][HTML] BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism

MA Robinson-Agramonte, B Michalski… - Scientific Reports, 2022 - nature.com
Brain-derived neurotrophic factor (BDNF) and insulin-like growth factor 1 (IGF-1) promote
the development and maintenance of neural circuits. Alterations in these factors might …

PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics

T Stevens, K Sangkuhl, JT Brown… - Pharmacogenetics …, 2019 - journals.lww.com
Overview Methylphenidate (MPH) is a central nervous system stimulant primarily used for
the treatment of attention deficit hyperactivity disorder (ADHD). MPH works by preventing the …

[HTML][HTML] Increased serum brain-derived neurotrophic factor, nerve growth factor, glial-derived neurotrophic factor and galanin levels in children with attention deficit …

C Gumus, IP Yazici, KU Yazici… - Clinical …, 2022 - ncbi.nlm.nih.gov
Objective This study aimed to investigate the levels of serum brain-derived neurotrophic
factor (BDNF), nerve growth factor (NGF), glial cell-derived neurotrophic factor (GDNF) and …

[HTML][HTML] Emotional and sensory dysregulation as a possible missing link in attention deficit hyperactivity disorder: A review

A Grossman, A Avital - Frontiers in Behavioral Neuroscience, 2023 - frontiersin.org
Attention Deficit Hyperactivity Disorder (ADHD) is a common developmental disorder
affecting 5-7% of adults and children. We surveyed the literature to examine ADHD through …

Altered serum levels of vascular endothelial growth factor and glial-derived neurotrophic factor but not fibroblast growth factor-2 in treatment-naive children with …

N Yurteri, İE Şahin, AE Tufan - Nordic journal of psychiatry, 2019 - Taylor & Francis
Background and aim: Recent evidence suggests that growth factors might be involved in the
pathophysiology of attention deficit hyperactivity disorder (ADHD). The aim of this study was …

Brain-derived neurotrophic factor (BDNF) levels in children and adolescents before and after stimulant use a systematic review and metanalysis

MS de Lucca, MEO Pimentel, CKO Raimundo… - Progress in Neuro …, 2023 - Elsevier
Background Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental
disorder associated with cognitive, social, and academic impairment. Neurotrophins …

Investigation of possible associations of the BDNF, SNAP-25 and SYN III genes with the neurocognitive measures: BDNF and SNAP-25 genes might be involved in attention …

H Bolat, G Ünsel-Bolat, S Özgül, E Parıltay… - Nordic Journal of …, 2022 - Taylor & Francis
Objectives Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous disorder and
Sluggish Cognitive Tempo (SCT) might be a second inattention disorder that might be even …